Management of neuropathic pain - Translating mechanistic advances and evidence-based research into clinical practice

被引:32
作者
Gallagher, RM
机构
[1] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA
关键词
neuropathic pain; management; evidence-based;
D O I
10.1097/01.ajp.0000193827.07453.d6
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The concept of rational polypharmacy is now well established in the field of pain management. This concept has evolved in concert with progress in understanding the pathophysiologic mechanisms of pain diseases and disorders and how medications affect these processes. Other clinical factors must be considered in formulating the pain management strategy most likely to succeed in both controlling pain and improving function in a given patient. This article will review how pain diagnosis, pain mechanisms, pain phenomenology, medication efficacy, and risk profile influence medication selection in pain medicine practice, with a selective focus on the treatment of neuropathic pain. In addition, the role of psychosocial factors as they affect pain managernent will be discussed.
引用
收藏
页码:S2 / S8
页数:7
相关论文
共 31 条
[1]   Effects of single and repeated applications of a eutectic mixture of local anaesthetics (EMLA®) cream on spontaneous and evoked pain in post-herpetic neuralgia [J].
Attal, N ;
Brasseur, L ;
Chauvin, M ;
Bouhassira, D .
PAIN, 1999, 81 (1-2) :203-209
[2]   TOPICAL CAPSAICIN TREATMENT OF CHRONIC POSTHERPETIC NEURALGIA [J].
BERNSTEIN, JE ;
KORMAN, NJ ;
BICKERS, DR ;
DAHL, MV ;
MILLIKAN, LE .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (02) :265-270
[3]   Mechanistic stratification of antineuralgic agents [J].
Beydoun, A ;
Backonja, MM .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (05) :S18-S30
[4]   Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate [J].
Coderre, TJ ;
Kumar, N ;
Lefebvre, CD ;
Yu, JSC .
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (04) :1131-1139
[5]   Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review [J].
Collins, SL ;
Moore, RA ;
McQuay, HJ ;
Wiffen, P .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (06) :449-458
[6]   Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia [J].
Davies, PS ;
Galer, BS .
DRUGS, 2004, 64 (09) :937-947
[7]   Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses [J].
Dohrenwend, BP ;
Raphael, KG ;
Marbach, JJ ;
Gallagher, RM .
PAIN, 1999, 83 (02) :183-192
[8]   Practice parameter: Treatment of postherpetic neuralgia an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology [J].
Dubinsky, RM ;
Kabbani, H ;
El-Chami, Z ;
Boutwell, C ;
Ali, H .
NEUROLOGY, 2004, 63 (06) :959-965
[9]   Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy [J].
Flatters, SJL ;
Bennett, GJ .
PAIN, 2004, 109 (1-2) :150-161
[10]   Neuropathic pain of peripheral origin: Advances in pharmacologic treatment [J].
Galer, BS .
NEUROLOGY, 1995, 45 (12) :S17-S25